BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9151877)

  • 1. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins.
    Lindemann D; Bock M; Schweizer M; Rethwilm A
    J Virol; 1997 Jun; 71(6):4815-20. PubMed ID: 9151877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.
    Höhne M; Thaler S; Dudda JC; Groner B; Schnierle BS
    Virology; 1999 Aug; 261(1):70-8. PubMed ID: 10441556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foamy virus capsids require the cognate envelope protein for particle export.
    Pietschmann T; Heinkelein M; Heldmann M; Zentgraf H; Rethwilm A; Lindemann D
    J Virol; 1999 Apr; 73(4):2613-21. PubMed ID: 10074106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vector system for introducing foreign HIV-1 env genes and pseudotyping of MuLV particles with the recombinant HIV-1 envelope proteins for anti-HIV-1 assay.
    Lee MK; Seo JK; Kim HK; Cho JH; Poo H; Kim KL
    Antiviral Res; 2002 Feb; 53(2):99-111. PubMed ID: 11750936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors.
    Christodoulopoulos I; Cannon PM
    J Virol; 2001 May; 75(9):4129-38. PubMed ID: 11287562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication-competent hybrids between murine leukemia virus and foamy virus.
    Shikova-Lekova E; Lindemann D; Pietschmann T; Juretzek T; Rudolph W; Herchenröder O; Gelderblom HR; Rethwilm A
    J Virol; 2003 Jul; 77(13):7677-81. PubMed ID: 12805469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions.
    Denesvre C; Carrington C; Corbin A; Takeuchi Y; Cosset FL; Schulz T; Sitbon M; Sonigo P
    J Virol; 1996 Jul; 70(7):4380-6. PubMed ID: 8676461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
    Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
    Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.
    Kiernan RE; Freed EO
    J Virol; 1998 Dec; 72(12):9621-7. PubMed ID: 9811695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of the env genes and the endonuclease domain of the pol genes of simian foamy virus type 1 and human foamy virus.
    Mergia A; Shaw KE; Lackner JE; Luciw PA
    J Virol; 1990 Jan; 64(1):406-10. PubMed ID: 2152825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells.
    Schnierle BS; Stitz J; Bosch V; Nocken F; Merget-Millitzer H; Engelstädter M; Kurth R; Groner B; Cichutek K
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8640-5. PubMed ID: 9238030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide.
    Yang C; Compans RW
    J Virol; 1996 Jan; 70(1):248-54. PubMed ID: 8523533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.
    Song YE; Olinger GY; Janaka SK; Johnson MC
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequences present in a small region of the AKV virus envelope gene determine the efficiency with which pseudotyped spleen focus-forming virus infects erythroid target cells.
    Muenchau DD; Ruscetti S; Anderson WF
    Virology; 1992 Jan; 186(1):161-6. PubMed ID: 1309273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing.
    Lindemann D; Rethwilm A
    J Virol; 1998 May; 72(5):4088-94. PubMed ID: 9557698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
    Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW
    J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
    Sandrin V; Muriaux D; Darlix JL; Cosset FL
    J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus release.
    Noble B; Abada P; Nunez-Iglesias J; Cannon PM
    J Virol; 2006 Mar; 80(6):2924-32. PubMed ID: 16501101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foamy virus vectors.
    Russell DW; Miller AD
    J Virol; 1996 Jan; 70(1):217-22. PubMed ID: 8523528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional murine leukemia virus vectors pseudotyped with the visna virus envelope show expanded visna virus cell tropism.
    Bruett L; Clements JE
    J Virol; 2001 Dec; 75(23):11464-73. PubMed ID: 11689628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.